2020
DOI: 10.1001/jamadermatol.2020.0135
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Point-of-Care Decision Support for Adult Acne Treatment by Primary Care Clinicians

Abstract: cne is a chronic inflammatory skin disease that affects more than 85% of adolescents and frequently continues to adulthood. [1][2][3][4] Although there is a high diagnostic concordance for acne between dermatologists and primary care clinicians, acne continues to be a common indication for referral to a dermatologist. 5,6 Although referrals to dermatologists for acne are not discouraged, there are consequences of immediate referral by primary care clinicians who do not provide treatment, including delayed trea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 27 publications
0
2
0
Order By: Relevance
“…[32][33][34] However, these findings also suggest that patients with cirAEs evaluated outside of the dermatology setting may have significant unaddressed symptoms, meriting refined approaches to care delivery. Potential innovations targeting providers could include integration of clinical decision support systems encouraging NCCN-based treatment, development of care pathways to standardize referral processes by cirAE subtype, 47 and evaluation of care modalities with the potential to enhance access, such as teledermatology. [48][49][50] Early provision of patient-facing educational resources detailing cirAE manifestations and over-the-counter therapies could also facilitate symptom disclosure and receipt of appropriate treatment.…”
Section: Discussionmentioning
confidence: 99%
“…[32][33][34] However, these findings also suggest that patients with cirAEs evaluated outside of the dermatology setting may have significant unaddressed symptoms, meriting refined approaches to care delivery. Potential innovations targeting providers could include integration of clinical decision support systems encouraging NCCN-based treatment, development of care pathways to standardize referral processes by cirAE subtype, 47 and evaluation of care modalities with the potential to enhance access, such as teledermatology. [48][49][50] Early provision of patient-facing educational resources detailing cirAE manifestations and over-the-counter therapies could also facilitate symptom disclosure and receipt of appropriate treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Managing acne scars is a challenge, 7‐10 and therapies are divided into nonsurgical and surgical. The former includes anti‐acne agents, 11,12 chemical peels, 13 microneedling, 14‐17 and ablative 18 and nonablative fractional 19‐22 and nonfractional 23 lasers, as well as autologous growth factors 24‐27 .…”
Section: Introductionmentioning
confidence: 99%